April 17, 2025 CPEAR Applauds Reintroduction of STATES 2.0 Act Urges Common-Sense Cannabis Reform Rooted in Federalism WASHINGTON, D.C. – Today, the Coalition for Cannabis Policy, Education, and Regulation (CPEAR) applauded the reintroduction of...
SYDNEY, AUSTRALIA – Australian Medicinal Cannabis company Cannim have partnered with the National Institute of Complementary Medicine (Western Sydney University) on groundbreaking studies examining the effectiveness of medicinal cannabis in treating women’s health;...
On Wednesday, April 9th, Jonathan Miller, General Counsel for the U.S. Hemp Roundtable, testified before the House Oversight Committee during a hearing titled “Restoring Trust in FDA: Rooting Out Illicit Products.” Throughout the hearing, Jonathan highlighted the...
Lower Saxony introduces catalog of fines for cannabis use 2025-04-08 | In Lower Saxony, adults will face fines of up to 1,000 euros for cannabis use in sensitive areas, LTO reports. A new state-wide catalog serves as a guide for municipalities for violations of the...
German Cannabis Biz Assoc writes 2025-04-09 | CDU, CSU and SPD have not agreed to reverse the partial legalization of cannabis in their new coalition agreement. The law will therefore remain in force for the time being, reports mdr. Instead, a scientifically sound...
A landmark vote at the recent 68th United Nations Commission on Narcotic Drugs (UNCND) revealed cracks in the UN’s previous unanimous approach to drug control. In a resolution spearheaded by Colombia and backed by a majority of member states, a panel of independent...
14 April 2025 The Therapeutic Goods Administration (TGA) issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products. Summit Pharmacy Pty Ltd paid all 4...
BACKGROUND The landmark introduction of The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 [1]paved the way for legalised access to medicinal cannabis in the UK. Medicinal cannabis was subsequently defined as a...
CBD products marketed for medical purposes Products containing cannabidiol (CBD) used for medical purposes are medicines. If a company markets a CBD containing product that makes a medicinal claim it will be considered to fall within the definition of a medical...
Spotofy Link Coming Soon DOWNLOAD FOR FREE AT PODOMATIC https://www.podomatic.com/podcasts/karmakoalapodcast/episodes/2025-04-16T07_22_41-07_00 In the run up the Australian federal election and the Nimbin Mardigrass (2-4 May 2025) we talk to Andrew Kavisilas...
